Your session is about to expire
← Back to Search
Protoporphyrin IX Measurement for Photodynamic Therapy
Study Summary
This trial is testing a new way to measure how well a skin cancer treatment is working. They will apply a drug to people's skin and then use a new device to measure how much of the drug is absorbed. They will also measure the person's skin temperature and skin type to see if these factors affect how well the drug is absorbed.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am unable to give consent for myself.I am 18 or older and visiting the Dartmouth-Hitchcock Dermatology Clinic.I am under the age of 18.
- Group 1: Ameluz (amino-levulinic acid topical gel) Only
- Group 2: Ameluz and Light Therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the age of a potential participant affect their eligibility for this research study?
"Applicants who are between 18 and 75 years of age will be considered for participation in this clinical trial."
What medical applications is Ameluz (amino-levulinic acid topical gel) typically employed in?
"Ameluz (amino-levulinic acid topical gel) is typically administered to treat scalp structure, but can also be deployed in the management of carcinoma, squamous cell carcinoma and facial lesions."
Are there available slots for participants in this trial?
"According to clinicaltrials.gov, this medical study, first posted on December 1st 2022 is no longer actively recruiting patients. However, there are 41 other trials that require participants at this time."
How many participants are capably being admitted into this research endeavor?
"This trial is not presently accepting applicants. It was initially uploaded on December 1st 2022 and last revised a few months later, on March 21st 2021. If you are searching for other trials, there are currently 23 clinical studies looking to recruit participants with photochemotherapy and 18 research initiatives focused on Ameluz (amino-levulinic acid topical gel). These programmes only welcome actively enrolling individuals."
Has research surrounding the efficacy of Ameluz (amino-levulinic acid topical gel) been conducted independently?
"Currently, 18 studies are ongoing for Ameluz (amino-levulinic acid topical gel) Only. Out of these trials, 2 have reached Phase 3 status and they are all located in Lebanon, New hampshire. Nevertheless, 56 locations across the country host different clinical trials dedicated to this treatment."
What criteria do participants need to meet in order to be accepted into this medical study?
"This trial is accepting 50 volunteers aged 18 to 75 who already receive photodynamic therapy treatment at Dartmouth-Hitchcock Medical Center Heater Road Dermatology Clinic. Furthermore, other individuals seen in the clinic without a prescription for this form of photochemotherapy are also eligible to participate."
Share this study with friends
Copy Link
Messenger